Search Results

There are 2877 results for: content related to: Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse

  1. Basic pharmacology of buprenorphine

    European Journal of Pain Supplements

    Volume 1, Issue S1, September 2007, Pages: 69–73, Michiteru Ohtani

    Version of Record online : 6 JAN 2012, DOI: 10.1016/S1754-3207(08)60017-6

  2. UHPLC-MS/MS quantification of buprenorphine, norbuprenorphine, methadone, and glucuronide conjugates in umbilical cord plasma

    Biomedical Chromatography

    Volume 29, Issue 10, October 2015, Pages: 1567–1574, Amy Redmond Kyle, Jennifer Carmical, Darshan Shah, Jason Pryor and Stacy Brown

    Version of Record online : 22 MAR 2015, DOI: 10.1002/bmc.3460

  3. Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal Outcomes

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 5, November 2008, Pages: 604–612, SL Kacinko, HE Jones, RE Johnson, RE Choo and MA Huestis

    Version of Record online : 13 AUG 2008, DOI: 10.1038/clpt.2008.156

  4. Buprenorphine exposure in infants of opioid-dependent mothers at birth

    Australian and New Zealand Journal of Obstetrics and Gynaecology

    Volume 52, Issue 4, August 2012, Pages: 342–347, Anne E. Bartu, Kenneth F. Ilett, L. Peter Hackett, Dorota A. Doherty and Dale Hamilton

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1479-828X.2012.01424.x

  5. Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements: in vitro proof of concept

    Biopharmaceutics & Drug Disposition

    Volume 38, Issue 2, March 2017, Pages: 139–154, Neha V. Maharao, Anand A. Joshi and Phillip M. Gerk

    Version of Record online : 24 JAN 2017, DOI: 10.1002/bdd.2050

  6. Buprenorphine

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 514–526, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch28

  7. Meconium drug testing reveals maternal misuse of medicinal opioids among addicted mothers

    Drug Testing and Analysis

    Volume 5, Issue 7, July 2013, Pages: 529–533, Terhi Launiainen, Irmeli Nupponen, Erja Halmesmäki and Ilkka Ojanperä

    Version of Record online : 6 FEB 2013, DOI: 10.1002/dta.1459

  8. You have full text access to this OnlineOpen article
    Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects

    Pharmacology Research & Perspectives

    Volume 4, Issue 6, December 2016, Nora M. Hagelberg, Mari Fihlman, Tuija Hemmilä, Janne T. Backman, Jouko Laitila, Pertti J. Neuvonen, Kari Laine, Klaus T. Olkkola and Teijo I. Saari

    Version of Record online : 3 NOV 2016, DOI: 10.1002/prp2.271

  9. You have free access to this content
    Buprenorphine: An Analgesic with an Expanding Role in the Treatment of Opioid Addiction

    CNS Drug Reviews

    Volume 8, Issue 4, December 2002, Pages: 377–390, Susan E. Robinson

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2002.tb00235.x

  10. An injection depot formulation of buprenorphine: extended biodelivery and effects

    Addiction

    Volume 101, Issue 3, March 2006, Pages: 420–432, Stacey C. Sigmon, David E. Moody, Elie S. Nuwayser and George E. Bigelow

    Version of Record online : 27 FEB 2006, DOI: 10.1111/j.1360-0443.2006.01348.x

  11. You have free access to this content
    The In Vivo Response of Novel Buprenorphine Metabolites, M1 and M3, to Antiretroviral Inducers and Inhibitors of Buprenorphine Metabolism

    Basic & Clinical Pharmacology & Toxicology

    Volume 105, Issue 3, September 2009, Pages: 211–215, David E. Moody, Yan Chang, Wei Huang and Elinore F. McCance-Katz

    Version of Record online : 4 JUN 2009, DOI: 10.1111/j.1742-7843.2009.00432.x

  12. Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero

    Acta Paediatrica

    Volume 97, Issue 8, August 2008, Pages: 1040–1044, Timo Hytinantti, Hanna Kahila, Martin Renlund, Anna-Liisa Järvenpää, Erja Halmesmäki and Satu Kivitie-Kallio

    Version of Record online : 8 MAY 2008, DOI: 10.1111/j.1651-2227.2008.00838.x

  13. Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine

    European Journal of Pain

    Volume 10, Issue 8, November 2006, Page: 743, Jörg Filitz, Norbert Griessinger, Reinhard Sittl, Rudi Likar, Jürgen Schüttler and Wolfgang Koppert

    Version of Record online : 11 JAN 2012, DOI: 10.1016/j.ejpain.2005.12.001

  14. Interpretation of Urine Drug Testing Results in Patients Using Transdermal Buprenorphine Preparations for the Treatment of Chronic Noncancer Pain

    Pain Medicine

    Volume 16, Issue 6, June 2015, Pages: 1132–1136, John D. Markman, William A. Barbosa, Jennifer S. Gewandter, Maria Frazer, Shirley Rast, Michelle Dugan, Kiran Nandigam, Armando Villareal and Tai C. Kwong

    Version of Record online : 20 MAR 2015, DOI: 10.1111/pme.12740

  15. Pharmacokinetics of morphine and its surrogates X: Analyses and pharmacokinetics of buprenorphine in dogs

    Biopharmaceutics & Drug Disposition

    Volume 11, Issue 4, May/June 1990, Pages: 311–350, Edward R. Garrett and V. Ravi Chandran

    Version of Record online : 11 JAN 2006, DOI: 10.1002/bdd.2510110403

  16. You have free access to this content
    Buprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatment

    Drug Testing and Analysis

    Volume 6, Issue S1, June 2014, Pages: 93–100, Stamatis Belivanis, Manolis N. Tzatzarakis, Elena Vakonaki, Leda Kovatsi, Mary Mantsi, Athanasios Alegakis, Matthaios P. Kavvalakis, Dionisios Vynias and Aristidis M. Tsatsakis

    Version of Record online : 9 MAY 2014, DOI: 10.1002/dta.1611

  17. Buprenorphine withdrawal syndrome in a newborn

    Clinical Pharmacology & Therapeutics

    Volume 62, Issue 5, November 1997, Pages: 569–571, Pierre Marquet, Jean Chevrel, Pierre Lavignasse, Louis Merle and Gérard Lachâtre

    Version of Record online : 2 NOV 1997, DOI: 10.1016/S0009-9236(97)90053-9

  18. Urine naloxone concentration at different phases of buprenorphine maintenance treatment

    Drug Testing and Analysis

    Volume 6, Issue 3, March 2014, Pages: 220–225, Pertti Heikman, Margareeta Häkkinen, Merja Gergov and Ilkka Ojanperä

    Version of Record online : 19 MAR 2013, DOI: 10.1002/dta.1464

  19. Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site

    Veterinary Anaesthesia and Analgesia

    Volume 38, Issue 4, July 2011, Pages: 374–384, Kristen M Messenger, Jennifer L Davis, Douglas H LaFevers, Beth M Barlow and Lysa P Posner

    Version of Record online : 19 APR 2011, DOI: 10.1111/j.1467-2995.2011.00613.x

  20. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-β-D-glucuronide and norbuprenorphine-3-β-D-glucuronide in human plasma

    Journal of Mass Spectrometry

    Volume 40, Issue 1, January 2005, Pages: 70–74, Constance M. Murphy and Marilyn A. Huestis

    Version of Record online : 6 JAN 2005, DOI: 10.1002/jms.776